메뉴 건너뛰기




Volumn 23, Issue 12, 1996, Pages 2033-2038

Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: Longitudinal safety assessment and evidence of a pharmacokinetic / dynamic interaction

Author keywords

Cyclosporine; Diclofenac; Drug interaction; Rheumatoid arthritis

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; DICLOFENAC;

EID: 0030444303     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (18)

References (20)
  • 1
    • 0026689387 scopus 로고
    • Cyclosporine in rheumatoid arthritis: Documented efficacy and safety
    • Tugwell P: Cyclosporine in rheumatoid arthritis: Documented efficacy and safety. Semin Arthritis Rheum 1992;(suppl 3)21:30-8.
    • (1992) Semin Arthritis Rheum , vol.21 , Issue.3 SUPPL. , pp. 30-38
    • Tugwell, P.1
  • 3
    • 0029093391 scopus 로고
    • Cyclosporine in rheumatoid arthritis: An overview
    • Førre Ø: Cyclosporine in rheumatoid arthritis: An overview. Clin Rheumatol 1995;(suppl 2)14:33-6.
    • (1995) Clin Rheumatol , vol.14 , Issue.2 SUPPL. , pp. 33-36
    • Førre, Ø.1
  • 5
    • 0023105608 scopus 로고
    • Enhancement of cyclosporin A nephrotoxicity by diclofenac
    • Deray G, Le Hoang P, Aupetit B, et al: Enhancement of cyclosporin A nephrotoxicity by diclofenac (letter). Clin Nephrol 1987;27:213-4.
    • (1987) Clin Nephrol , vol.27 , pp. 213-214
    • Deray, G.1    Le Hoang, P.2    Aupetit, B.3
  • 6
    • 0023708322 scopus 로고
    • Nonsteroidal antiinflammatory drugs and cyclosporin: A potentially serious adverse interaction
    • Harris KP, Jenkins D, Walls J: Nonsteroidal antiinflammatory drugs and cyclosporin: A potentially serious adverse interaction (letter). Transplantation 1988;46:598-9.
    • (1988) Transplantation , vol.46 , pp. 598-599
    • Harris, K.P.1    Jenkins, D.2    Walls, J.3
  • 7
    • 0025970746 scopus 로고
    • Cyclosporin and diclofenac interaction in rheumatoid arthritis
    • Branthwaite JP, Nicholls A: Cyclosporin and diclofenac interaction in rheumatoid arthritis (letter). Lancet 1991;337:252.
    • (1991) Lancet , vol.337 , pp. 252
    • Branthwaite, J.P.1    Nicholls, A.2
  • 8
    • 0024410995 scopus 로고
    • Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis
    • Berg KJ, Førre Ø, Djoseland M, et al: Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis. Clin Nephrol 1989;31:232-8.
    • (1989) Clin Nephrol , vol.31 , pp. 232-238
    • Berg, K.J.1    Førre, Ø.2    Djoseland, M.3
  • 9
    • 0026673504 scopus 로고
    • Interaction of cyclosporin A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis
    • Altman RD, Perez GO, Sfakianakis GN: Interaction of cyclosporin A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis. Am J Med 1992;93:396-402.
    • (1992) Am J Med , vol.93 , pp. 396-402
    • Altman, R.D.1    Perez, G.O.2    Sfakianakis, G.N.3
  • 10
    • 0027360295 scopus 로고
    • Pharmacokinetics of cyclosporine and multiple-dose diclofenac during coadministration
    • Mueller EA, Kovarik JM, Koelle EU, et al: Pharmacokinetics of cyclosporine and multiple-dose diclofenac during coadministration. J Clin Pharmacol 1993;33:936-43.
    • (1993) J Clin Pharmacol , vol.33 , pp. 936-943
    • Mueller, E.A.1    Kovarik, J.M.2    Koelle, E.U.3
  • 11
    • 0023945481 scopus 로고
    • American rheumatism association 1987 revised criteria for the classification of RA
    • Arnett FC, Edworthy SM, Bloch DA, et al: American rheumatism association 1987 revised criteria for the classification of RA. Arthritis Rheum 1988;31:315-24.
    • (1988) Arthritis Rheum , vol.31 , pp. 315-324
    • Arnett, F.C.1    Edworthy, S.M.2    Bloch, D.A.3
  • 12
    • 0023818445 scopus 로고
    • 3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in blood
    • 3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in blood. Clin Chem 1988;34:257-60.
    • (1988) Clin Chem , vol.34 , pp. 257-260
    • Ball, P.E.1    Munzer, H.2    Keller, H.P.3
  • 13
    • 0025861932 scopus 로고
    • The relative bioavailability of diclofenac with respect to time of administration
    • Mustofa M, Suryawati S, Dwiprahasto I, Santoso B: The relative bioavailability of diclofenac with respect to time of administration. Br J Clin Pharmacol 1991;32:246-7.
    • (1991) Br J Clin Pharmacol , vol.32 , pp. 246-247
    • Mustofa, M.1    Suryawati, S.2    Dwiprahasto, I.3    Santoso, B.4
  • 14
    • 0023976547 scopus 로고
    • Diclofenac sodium: A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy
    • Todd PA, Sorkin EM: Diclofenac sodium: A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1988;35:244-85.
    • (1988) Drugs , vol.35 , pp. 244-285
    • Todd, P.A.1    Sorkin, E.M.2
  • 15
    • 0027193864 scopus 로고
    • Pharmacokinetics of cyclosporine and steady-state aspirin during coadministration
    • Kovarik JM, Mueller EA, Gaber M, et al: Pharmacokinetics of cyclosporine and steady-state aspirin during coadministration. J Clin Pharmacol 1993;13:513-21.
    • (1993) J Clin Pharmacol , vol.13 , pp. 513-521
    • Kovarik, J.M.1    Mueller, E.A.2    Gaber, M.3
  • 16
    • 0344634038 scopus 로고
    • NSAIDs from various chemical classes competitively inhibit P450TB (CYP2C)
    • Leeman TD, Kondo M, Dayer P: NSAIDs from various chemical classes competitively inhibit P450TB (CYP2C) (abstr). Clin Pharmacol Ther 1992;51:179.
    • (1992) Clin Pharmacol Ther , vol.51 , pp. 179
    • Leeman, T.D.1    Kondo, M.2    Dayer, P.3
  • 17
    • 0024208892 scopus 로고
    • Cyclosporin A in severe, treatment-refractory rheumatoid arthritis
    • Yocum DE, Klippel JH, Wilder RL, et al: Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. Ann Intern Med 1988;109:863-9.
    • (1988) Ann Intern Med , vol.109 , pp. 863-869
    • Yocum, D.E.1    Klippel, J.H.2    Wilder, R.L.3
  • 18
    • 0023897330 scopus 로고
    • Serum creatinine levels two years later: Follow-up of a placebo-controlled trial of cyclosporine in rheumatoid arthritis patients
    • Boers M, van Rijthoven AWAM, Goei The HS, et al: Serum creatinine levels two years later: Follow-up of a placebo-controlled trial of cyclosporine in rheumatoid arthritis patients. Transplant Proc 1988;(suppl 4)3:371-5.
    • (1988) Transplant Proc , vol.3 , Issue.4 SUPPL. , pp. 371-375
    • Boers, M.1    Van Rijthoven, A.W.A.M.2    Goei The, H.S.3
  • 19
    • 0026694617 scopus 로고
    • Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases
    • Feutren G, Mihatsch MJ: Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992;326:1654-60.
    • (1992) N Engl J Med , vol.326 , pp. 1654-1660
    • Feutren, G.1    Mihatsch, M.J.2
  • 20
    • 0027960223 scopus 로고
    • The use of cyclosporin A in rheumatoid arthritis. Conclusions of an international review
    • Panayi GS, Tugwell P: The use of cyclosporin A in rheumatoid arthritis. Conclusions of an international review. Br J Rheumatol 1994;33:967-9.
    • (1994) Br J Rheumatol , vol.33 , pp. 967-969
    • Panayi, G.S.1    Tugwell, P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.